Release Date: 02/05/22 16:44 Summary: Final Director's Interest Notice Price Sensitive: No Download Document 460.33KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%